retatrutide what is it clinical trial Phase III study demonstrates 30% weight loss Retatrutide—A Game Changer in Obesity

What to Expect in Month 1 Appetite changes: Noticeable suppression begins week 3-4 for most Mild nausea: 40% experience some nausea, usually mild Injection site reactions: Redness, itching, or mild pain at injection site (14% of patients) Fatigue: Some patients report low energy as body adjusts Bowel changes: Either constipation or looser stools as medication affects gut motility 4 Essential Strategies for Month 1 1

However, ongoing monitoring is crucial to identify any adverse effects, such as gastrointestinal issues or metabolic changes

Whether its the sustained energy, the progressive weight loss, or the flourishing radiance of your skin and hair, these are the dividends of your commitment to wellness

After this process, it produces another molecule, and the action starts again

To do otherwise will interfere with the slow release of this drug, and make it less effective

He wants you to be cautious when using compounded GLP-1s, which are copycat versions that dont have FDA approval